MedPath

Effect of Apatarpankar Hetus on Krusha Pramehi (low BMI Diabetic patients) and their Blood Sugar Level

Not yet recruiting
Conditions
Diabetes mellitus,
Registration Number
CTRI/2018/11/016321
Lead Sponsor
PDEAs College of Ayurved and Research Center
Brief Summary

Diabetes is growing in a rapid pace around the world. India is harbouring many patients which are diabetic but with low Body Mass Index, which is the concept of Diabetes Paradox. Such patients are prone to more complication and there is high mortality rate in these individuals, however the reason to this is not known. Diabetes is closely related to the concept of prameha explained in Ayurved. Charak specifically describes two types of pramehis in Charak Chikitsasthan as sthoola and krusha pramehis, hence it is quite evident that treatment for both is different one is apatarpan and other is santarpan respectively.

The present trend in our society is that once serum glucose levels are found to be a bit high there is unprecedented and sudden cut down of fats, oils, all things which tastes sweet from the diet and overuse of exercise and other methods in a desperate attempt to control BSL. Irrespective of the body type of the patient. it has been proved that incidence of mortality is more in individuals having low BMI with diabetes, this includes the Asian Indian phenotype or the Krusha pramehi.

The aim of this research is to identify what effects the present protocol and trend of strenuous exercises, cutting down normal food requirements and haphazard consumption of medications is having on krusha pramehis as a desperate attempt to control objective parameters like BSL. Krusha pramehi’s and their BSL will be observed for effect of apatarpankar hetus.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Individuals having B.M.I less than 18.5 Individuals having FBSL > 125 mg/dl or PPBSL > 200 mg/dl.

Exclusion Criteria

Known case of HIV, Tuberculosis, Hyperthyroidism, Malignancy.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Descriptive studyUpadravas of prameha will be assessed in the patient
Secondary Outcome Measures
NameTimeMethod
Descriptive studylakshanas of Vata Prakopa will be assessed in the patient

Trial Locations

Locations (1)

Pathology laboratory, Room No 115, Ayurved Rugnalay and Sterling Multispeciality Hospital

🇮🇳

Pune, MAHARASHTRA, India

Pathology laboratory, Room No 115, Ayurved Rugnalay and Sterling Multispeciality Hospital
🇮🇳Pune, MAHARASHTRA, India
Dr Advait Murli Menon
Principal investigator
7875150722
ssadvaitmenon93@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.